RecruitingEarly Phase 1NCT07109258

Effect of Dexamethasone on Labour Induction in Term Pregnancies


Sponsor

Cairo University

Enrollment

150 participants

Start Date

May 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to assess the effect of dexamethasone on labour induction in term pregnancies. Primary outcome: The interval between initiation of induction and beginning of the active phase of labour. Secondary outcomes: * Duration of active phase of labour (starting with cervical dilatation of 4-5 cm up to full cervical dilatation). * Duration of second stage of labour * Mode of delivery. * Fetal outcome. Group A: Will receive one dose of IM dexamethasone sodium phosphate 8 mg (2 mL). Group B: Will receive vaginal misoprostol 25 μg tablets every 6 h, up to 4 tablets, for a maximum duration of 24 h. Group C: Will receive one dose of IM dexamethasone sodium phosphate 8mg (2mL) with the first dose of vaginal misoprostol 25 μg tablets that will be given every 6 h, up to 4 tablets, for a maximum duration of 24 h.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Both Misoprostol 25 mcg & Dexamethasone 8mg IM injection, a drug called Dexamethasone (Decadron) 8mg IM injection, and others for people with labor induction. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexamethasone (Decadron) 8mg IM injection

one dose of IM dexamethasone sodium phosphate 8 mg (2 mL) given at the start of labour induction

DRUGMisoprostol 25 mcg

vaginal misoprostol 25 μg tablets every 6 h, up to 4 tablets, for a maximum duration of 24 h.

DRUGBoth Misoprostol 25 mcg & Dexamethasone 8mg IM injection

one dose of IM dexamethasone sodium phosphate 8mg (2mL) with the first dose of vaginal misoprostol 25 μg tablets that will be given every 6 h, up to 4 tablets, for a maximum duration of 24 h.


Locations(1)

Cairo University Hospital (Kasr Al Ainy)

Cairo, Manial, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07109258


Related Trials